Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fadima Cheick Haidara

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMJ Open|August 30, 2023
Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in MaliAmanda J Driscoll, Fadima Cheick Haidara, Milagritos D Tapia, et al.
Clinical and Vaccine Immunology : CVI|July 15, 2011
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlersHelen Findlow, Samba Sow, Ray Borrow, et al.
The New England Journal of Medicine|October 15, 2025
Mass Administration of Azithromycin to Infants in Mali to Reduce MortalityFadima Cheick Haidara, Laura Adubra, Mahamadou Abdou, et al.
Vaccine|September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlersAbraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of AgeMilagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate VaccineLionel Martellet, Samba O Sow, Aldiouma Diallo, et al.
The New England Journal of Medicine|June 17, 2011
Immunogenicity and safety of a meningococcal A conjugate vaccine in AfricansSamba O Sow, Brown J Okoko, Aldiouma Diallo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 YearsAldiouma Diallo, Samba O Sow, Olubukola T Idoko, et al.
The Lancet. Infectious Diseases|June 5, 2016
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trialMilagritos D Tapia, Samba O Sow, Boubou Tamboura, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMJ Open|August 30, 2023
Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in MaliAmanda J Driscoll, Fadima Cheick Haidara, Milagritos D Tapia, et al.
Clinical and Vaccine Immunology : CVI|July 15, 2011
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlersHelen Findlow, Samba Sow, Ray Borrow, et al.
The New England Journal of Medicine|October 15, 2025
Mass Administration of Azithromycin to Infants in Mali to Reduce MortalityFadima Cheick Haidara, Laura Adubra, Mahamadou Abdou, et al.
Vaccine|September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlersAbraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of AgeMilagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate VaccineLionel Martellet, Samba O Sow, Aldiouma Diallo, et al.
The New England Journal of Medicine|June 17, 2011
Immunogenicity and safety of a meningococcal A conjugate vaccine in AfricansSamba O Sow, Brown J Okoko, Aldiouma Diallo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 YearsAldiouma Diallo, Samba O Sow, Olubukola T Idoko, et al.
The Lancet. Infectious Diseases|June 5, 2016
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trialMilagritos D Tapia, Samba O Sow, Boubou Tamboura, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Pageof 3